Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

HYPERBOOST

Financiado

Cerrado

Creation of advanced cancer treatment planning to boost the effect of Radiothera...

Creation of advanced cancer treatment planning to boost the effect of Radiotherapy by combining with hyperthermia heating the tumor. Hyperthermia (HT), heating tumors to temperatures of 40-44°C, is an oncological treatment used in combination with radiotherapy (RT) and chemotherapy to enhance their efficacy. Clinical effectiveness of HT has been demonstrated in... ver más

30/11/2024

STICHTING AMSTERDA...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

STICHTING AMSTERDAM UMC No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 11 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2024-11-30

MSCA-ITN-2020: Innovative Training Networks

I+D

Cerrada hace 5 años

0% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

11 Participantes

STICHTING AMSTERDAM UMC

531.24K€ | Lider

MARTINEZ NIETO

196.58K€ | Participante

DR SENNEWALD MEDIZINTECHNIK...

252.79K€ | Participante

Universitätsklinikum Erlange...

505.58K€ | Participante

Proyectos interesantes

HyperCollar3D

Medical Technol...

Data Science

71K€ Cerrado

THERMOGUIDE

Medical Technol...

Applied Physics

188K€ Cerrado

HyperCollar4D

Medical Technol...

Applied Physics

9M€ Cerrado

PDC2022-133028-I00

Medical Technol...

Nanotechnology

138K€ Cerrado

CPP2021-008368

Medical Technol...

Data Science

288K€ Cerrado

DIRECT

Medical Technol...

Applied Physics

2M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 51 meses Fecha Inicio: 2020-08-13
Fecha Fin: 2024-11-30

Líder del proyecto

STICHTING AMSTERDAM UMC No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Hyperthermia (HT), heating tumors to temperatures of 40-44°C, is an oncological treatment used in combination with radiotherapy (RT) and chemotherapy to enhance their efficacy. Clinical effectiveness of HT has been demonstrated in randomised studies and HT is currently applied for many clinical indications, like cervical cancer and recurrent breast cancer. Clinical results can be further improved as application of HT with well-controlled tumor temperatures and optimal timing and sequence realising full synergy of RT+HT is challenging. Optimal HT delivery requires accurate planning, moreover preclinical research has shown that many mechanisms are responsible for the therapeutic effect of HT, all presumably with a different temperature-effect relationship and with different optimal timing between RT and HT. Optimisation of clinical RT+HT treatments therefore requires a quantum leap in understanding and in clinical application. Scientific objective of this multidisciplinary project with contributions from all sectors and disciplines (biology, physics and oncology) is to combine training and research into the synergistic molecular mechanisms responsible for the therapeutic effect of HT on RT with the development of a versatile and innovative planning platform which utilises biological knowledge to achieve optimal patient-specific treatment delivery and ultimately application in a clinical registration study in a network of European centres implementing this treatment planning software to ensure optimal treatment delivery. This ground-breaking and multidisciplinary project with contributions from biology, physics and oncology will create a versatile and innovative planning platform, enhance fundamental knowledge and create practical tools to achieve personalised treatment, thereby augmenting treatment delivery and clinical results. The projects will also educate 15 highly skilled professionals capable of addressing and solving complex oncological issues.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores